• Dr Simon Thomson
  • About
    • Private patients
    • Medical legal expert
    • Industry consultancy
  • Understanding
    persistent pain
    • What is persistent pain?
    • Back and leg pain
    • Neuropathic pain
    • CRPS
    • Medical questionnaire
  • Treatments for
    persistent pain
    • Implantable pain treatments
      • Spinal cord stimulation
      • Multifidus nerve stimulation
    • Precision-guided pain treatment
      • Targeted injections
      • Targeted radiofrequency
  • News
    & events
  • Research &
    case studies
  • Get in touch

Infection Rate of Spinal Cord Stimulators After a Screening Trial Period. A 53-Month Third Party Follow-up

Operator | 1st August 2010

Spinal cord stimulator (SCS) infections are common (2.5–13%) and may cause harm. It is unclear if a screening trial with definitive leads presents an increased infection risk.

Categories:
← Demographic Characteristics of Patients with Severe Neuropathic Pain Secondary to Failed Back Surgery Syndrome
An International Survey to Understand Infection Control Practices for Spinal Cord Stimulation →